MedTrace Logo

Selenium Supplementation of Patients With Cirrhosis

NCT00271245 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2012-03-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether patients with liver cirrhosis can improve their selenium nutritional status by taking supplemental selenium.

Conditions

Interventions

DIETARY_SUPPLEMENT

200 µg selenium as selenate

200 µg selenium as selenate

DIETARY_SUPPLEMENT

400 µg selenium as selenate

400 µg selenium as selenate

DIETARY_SUPPLEMENT

200 µg selenium as selenomethionine

200 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Raymond F Burk, M.D. · Vanderbilt University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00271245 on ClinicalTrials.gov